The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
ResMed stock trades in the mid-$230s as of late August 2026, with investors balancing Q4 fiscal 2026 recall-related expenses against steady revenue growth and a forthcoming appearance at a major ...
Aug 7 (Reuters) - Shares of ResMed (RMD.N), opens new tab dropped about 6% in morning trade on Friday after the medtech company forecast fiscal 2027 revenue below Wall Street expectations, impacted by ...
RBC Capital Markets on Tuesday upgraded ResMed (RMD) to Outperform from Sector Perform and raised its price target to $262 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results